GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Evogene Ltd.
Evogene is an Israeli company using AI to develop new products in agriculture and medicine. Its stock price is a bet on the success of its computing platform and its subsidiaries in areas such as developing sustainable crops and new drugs.
Share prices of companies in the market segment - AI
Evogene is an Israeli computational biology company that uses its AI platform to develop new products in agriculture and medicine. We've categorized it as an "AI" company, and the chart below shows how investors value companies with technology platforms.
Broad Market Index - GURU.Markets
Evogene is an Israeli biotech company that uses artificial intelligence to develop products in the agricultural and medical sectors. Its unique platform makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Evogene compares to it.
Change in the price of a company, segment, and market as a whole per day
EVGN - Daily change in the company's share price Evogene Ltd.
The daily fluctuations of Evogene Ltd.'s stock, which uses AI to develop life science products, reflect its sensitivity to news from various sectors, from agriculture to medicine. This metric is a measure of the success of its technology platform.
Daily change in the price of a set of shares in a market segment - AI
Evogene uses AI in biotechnology for agriculture and medicine, creating a high volatility profile. The chart below shows the average daily risk in the AI sector. It serves as a benchmark for assessing how EVGN shares measure up to the hype and risks of this cutting-edge industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Evogene is an Israeli company using artificial intelligence to develop products in agriculture and medicine. The company is located at the intersection of two hot sectors—AI and biotech. This creates high volatility, which contributes to overall market dynamics.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Evogene Ltd.
Evogene Ltd.'s year-over-year performance tells the story of its unique AI-powered computing platform. Its market capitalization over the past 12 months reflects the combined progress of its subsidiaries, which use this platform to develop new products in fields as diverse as agriculture, medicine, and industrial chemicals.
Annual dynamics of market capitalization of the market segment - AI
Evogene Ltd. is an Israeli company using AI to improve product development in agriculture and pharmaceuticals. Its technology platform is its key asset. The chart shows how the market values its diversified but high-risk model and its numerous subsidiaries.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Evogene, with its AI platform for life sciences, represents a diversified technology bet. Its performance relative to the market is the combined effect of its subsidiaries in agritech, healthcare, and manufacturing. Success in any of these areas could be a powerful growth driver.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Evogene Ltd.
Evogene is an Israeli company using AI for life sciences development. Its monthly performance reflects the successes of its subsidiaries in areas such as agricultural technology and medicine. News of breakthroughs or partnerships in either of these areas are driving the company's growth.
Monthly dynamics of market capitalization of the market segment - AI
Evogene Ltd. is an Israeli computational biology company using its AI platform to improve agricultural crops and discover new drugs and industrial chemicals. The AI sector's performance, shown in the graph, reflects rapid growth, allowing one to assess how its interdisciplinary scientific platform is being applied across various industries.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Evogene uses AI for developments in agriculture and pharmaceuticals. Its shares are a biotech-AI hybrid, volatile and loosely tied to the market. The chart will show movements driven by news of technological breakthroughs and partnerships, rather than by overall stock market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Evogene Ltd.
Evogene is an Israeli company using computational biology to develop products in agriculture, pharmaceuticals, and industrial applications. Its weekly stock price reflects progress in its numerous and diverse research programs.
Weekly dynamics of market capitalization of the market segment - AI
Evogene Ltd. uses artificial intelligence for developments in agriculture and pharmaceuticals. This chart compares the weekly performance of this AI company with its sectors. Is it outperforming the industry thanks to its technology, or is its stock moving with the flow?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Evogene Ltd., a company developing artificial intelligence for agriculture, is at the forefront of the tech hype. The chart below shows how strongly the company's shares are driving the NASDAQ index, serving as a barometer of investor appetite for risky growth stories in the AI space.
Market capitalization of the company, segment and market as a whole
EVGN - Market capitalization of the company Evogene Ltd.
Evogene's market capitalization represents a diversified bet on computational biology. This Israeli holding company's chart shows how investors value its AI platform and its applications through its subsidiaries in fields as diverse as agriculture, medicine, and industrial materials.
EVGN - Share of the company's market capitalization Evogene Ltd. within the market segment - AI
Evogene is an Israeli company that uses advanced computing technologies and artificial intelligence to improve product development processes in fields ranging from agriculture to medicine. Its market capitalization in the AI sector reflects its unique "computational biology" model. The company's size reflects its bet that its platform can accelerate innovation across multiple industries.
Market capitalization of the market segment - AI
Evogene is using AI to develop new products in agritech and pharmaceuticals. How big is this revolution? The graph below shows the pulse of the entire AI sector. Its explosive growth reflects how "predictive biology" is becoming a key tool for creating more productive crops and effective drugs.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Evogene chart shows how the market values a computing platform for life sciences. The Israeli company's market cap reflects its ability to use AI to improve agriculture, create new drugs, and develop industrial products. This diagram illustrates how big data is changing biotechnology.
Book value capitalization of the company, segment and market as a whole
EVGN - Book value capitalization of the company Evogene Ltd.
For Israeli company Evogene, which uses AI for research in agriculture and medicine, its book value lies in its powerful computing platform (CPB), laboratories, and greenhouses. The chart below shows how the company has invested in this unique technological and scientific foundation.
EVGN - Share of the company's book capitalization Evogene Ltd. within the market segment - AI
Evogene Ltd. is a computational biology company. Its main assets are not greenhouses, but powerful supercomputers and data centers, which serve as the "brains" of its gene and drug discovery platforms. The chart shows the share of this unique life sciences IT infrastructure the company controls.
Market segment balance sheet capitalization - AI
Evogene is an agritech company using AI. Compared to the capital-intensive sector, it's asset-light. The industry's asset chart reflects the value of farms. Evogene doesn't own any farms. Its capital is a computing platform for discovering new genes.
Book value of all companies included in the broad market index - GURU.Markets
Evogene's assets are not seeds, but a powerful AI-powered computing platform used to develop new solutions in agriculture (herbicides, insecticides) and medicine. Its book value reflects its unique technological foundation for "life design."
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Evogene Ltd.
Evogene is an Israeli company using AI to improve product development in agriculture, biofuels, and medicine. Its value lies in its computing platform. The chart shows how the market values this diversified model, which applies AI to various areas of the life sciences.
Market to book capitalization ratio in a market segment - AI
Evogene uses artificial intelligence to accelerate product development in agriculture and medicine. Its value lies in its computing platform. The chart shows that the market values its technology and its subsidiaries significantly higher than its tangible assets.
Market to book capitalization ratio for the market as a whole
Evogene uses AI to develop products in agriculture and medicine. Its computing platform and accumulated data are key assets. This chart illustrates the significant market premium placed on platform-based business models that can generate multiple products across industries.
Debts of the company, segment and market as a whole
EVGN - Company debts Evogene Ltd.
Evogene uses advanced computing technologies and artificial intelligence to accelerate product development in agriculture and pharmaceuticals. For such a science-intensive company, capital is essential to maintain its powerful computing platform and fund various research programs, which may be reflected in the dynamics in this chart.
Market segment debts - AI
Evogene is an Israeli company that uses computational biology and AI to develop products in agriculture and medicine. This interdisciplinary approach requires significant investment in R&D. This chart shows how the company funds its diverse research programs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Evogene Ltd.
Evogene is an Israeli company using AI for research in agriculture and biopharma. This chart shows the financial structure of a tech company with multiple research areas. Debt can be risky, as it requires stable revenue, while R&D success is not guaranteed.
Market segment debt to market segment book capitalization - AI
Evogene uses advanced computing platforms and AI to accelerate product development in agriculture and pharmaceuticals. This chart shows the overall debt burden in the sector, helping to understand how this unique company, at the intersection of biotech and IT, finances its expensive R&D platforms.
Debt to book value of all companies in the market
Evogene Ltd. is an Israeli company using computational biology and AI to develop products in agriculture and medicine. It is a knowledge-intensive platform. This chart, showing the traditional economy's debt, highlights that Evogene's funding depends on investors' faith in its technology platform, not traditional loans.
P/E of the company, segment and market as a whole
P/E - Evogene Ltd.
This chart for Evogene, an Israeli company using AI for biotech development, shows a speculative valuation. A price-to-earnings ratio (P/E) is not applicable. It's a bet that its computing platform will accelerate the development of new products in areas such as agriculture and medicine.
P/E of the market segment - AI
Evogene is a computational biology company that uses its AI platform to develop innovative products in agriculture and medicine. This chart shows the average valuation for the AI sector, helping to understand how the market values this unique scientific platform.
P/E of the market as a whole
Evogene is an Israeli company that uses artificial intelligence to accelerate developments in agriculture, biofuels, and medicine. Its valuation is a bet on its computing platform. It's not tied to general economic cycles, but depends on its ability to forge partnerships and prove the effectiveness of its approach across various industries.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Evogene Ltd.
Evogene uses its advanced AI-powered computational biology platform to develop innovative products in agriculture, pharmaceuticals, and industrial applications. This graph reflects expectations for its technology platform. Future revenue is dependent on the success of its subsidiaries and partnerships across various sectors.
%20P%2FE%20Evogene%20Ltd.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Evogene-Ltd.&v=1772624328821 "Chart of the company's future (projected) P/E Evogene Ltd.")
Future (projected) P/E of the market segment - AI
Evogene uses artificial intelligence to develop products in agriculture and pharmaceuticals. Its valuation, relative to other AI and biotech companies, reflects investor sentiment on its computing platform. This demonstrates whether investors believe in its ability to accelerate R&D and create innovative products, from seeds to drugs.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-AI&v=1772624328859 "Future (projected) P/E graph of the market segment - AI")
Future (projected) P/E of the market as a whole
Evogene uses artificial intelligence to develop products in agriculture, biofuels, and medicine. It's a platform company that applies its technology to various fields. This chart reflects overall investor sentiment toward AI and biotechnology, demonstrating the market's belief in the potential of computational biology to solve real-world problems.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772624328872 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Evogene Ltd.
Evogene is an Israeli company that uses computational biology and artificial intelligence to accelerate product development in fields such as agriculture, pharmaceuticals, and industrial chemicals. The financial performance shown here reflects investments in its unique AI platform.
Profit of companies in the market segment - AI
Evogene is an Israeli company using computational biology and AI to improve product development in agriculture, pharmaceuticals, and manufacturing. This chart shows the total revenue in the AI sector, helping to understand how versatile AI platforms can be successfully applied and monetized across such diverse industries.
Overall market profit
Evogene uses artificial intelligence to improve processes in agriculture and pharmaceuticals. It's a computational biology platform. Its success depends on the effectiveness of its algorithms and partnerships. This schedule is important for clients' R&D budgets, but EVGN's technology is its main asset.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Evogene Ltd.
Evogene uses artificial intelligence to develop products in agriculture and biotechnology. The company's future profitability depends on the success of its subsidiaries and the commercialization of their developments. This chart reflects analysts' confidence in its computing platform for creating innovative products.
%20profit%20of%20the%20company%20Evogene%20Ltd.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Evogene-Ltd.&v=1772624328931 "Graph of future (projected) profit of the company Evogene Ltd.")
Future (predicted) profit of companies in the market segment - AI
Evogene is an Israeli company using computational biology and artificial intelligence to improve product development in agriculture, pharmaceuticals, and manufacturing. This chart shows forecasts for the AI sector, illustrating how the use of advanced computing can accelerate innovation in traditional industries such as agritech and medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-AI&v=1772624328958 "Graph of future (predicted) profits of companies in a market segment - AI")
Future (predicted) profit of the market as a whole
This graph demonstrates agribusiness's willingness to invest in new technologies. Evogene, which uses AI to improve seeds and develop agrochemicals, is tapping into this trend. Economic growth and food demand are driving farmers to embrace innovation to increase yields.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772624328966 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Evogene Ltd.
Evogene uses computational biology and AI to develop products in agriculture and medicine. This metric reflects investors' confidence in its technology platform, which can generate revenue through partnerships and subsidiaries.
P/S market segment - AI
Evogene uses computational biology and artificial intelligence to accelerate product development in agriculture, pharmaceuticals, and manufacturing. This chart shows the average valuation in the AI sector, helping to understand the premium investors are willing to pay for Evogene's unique technology platform, which is applicable across multiple industries.
P/S of the market as a whole
Evogene Ltd. is an Israeli computational biology company that uses its AI platform to develop new products in agriculture, food production, and medicine. It's an innovation "factory." This chart helps assess how the market values the technology platform, not the final product.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Evogene Ltd.
Evogene uses artificial intelligence to accelerate product development in agriculture, pharmaceuticals, and industrial applications. Its future revenue depends on the success of its subsidiaries and partnerships. The chart demonstrates investors' confidence that its AI platform will lead to commercially successful products.
%20P%2FS%20Evogene%20Ltd.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Evogene-Ltd.&v=1772624329030 "The graph of the company's future (projected) P/S Evogene Ltd.")
Future (projected) P/S of the market segment - AI
Evogene is an Israeli computational biology company that uses AI to develop new products in agriculture (crop enhancement), human health (medicines), and industry (biomaterials). This chart shows how the market values its diversified AI platform.
%20P%2FS%20market%20segment%20graph%20-%20AI&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-AI&v=1772624329047 "Future (projected) P/S market segment graph - AI")
Future (projected) P/S of the market as a whole
This chart reflects expectations for the agritech sector. For Evogene, a company using AI to improve crops and develop new drugs, this is an indicator of faith in smart agriculture. Market optimism allows for funding for technologies that can improve crop yields and plant resilience.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772624329085 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Evogene Ltd.
Evogene is an Israeli computational biology company using artificial intelligence to develop innovative products in agriculture, pharmaceuticals, and industrial applications. This chart shows revenue from strategic partnerships and subsidiaries. This growth reflects the successful commercialization of its technology platform.
Sales of companies in the market segment - AI
Evogene Ltd. is an Israeli biotechnology company that uses artificial intelligence to develop products in fields such as agriculture, pharmaceuticals, and industrial chemicals. This chart reflects the explosive growth of the AI sector. Evogene's platform accelerates research and exemplifies how AI is transforming science.
Overall market sales
Evogene Ltd. uses computational biology and artificial intelligence to improve product development in agriculture and pharmaceuticals. Demand for its platform depends on R&D budgets in these industries. This pattern of overall economic activity influences companies' willingness to invest in advanced technologies to accelerate innovation.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Evogene Ltd.
Evogene uses an AI-powered computing platform to accelerate product development in agriculture (seeds, agrochemicals) and healthcare. This graph reflects analyst expectations for the success of its subsidiaries and partnerships in commercializing their products.
%20sales%20of%20the%20company%20Evogene%20Ltd.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Evogene-Ltd.&v=1772624329242 "Schedule of future (projected) sales of the company Evogene Ltd.")
Future (projected) sales of companies in the market segment - AI
Evogene uses computational biology and artificial intelligence to improve product development in agriculture and pharmaceuticals. This chart shows expectations for the overall AI market, illustrating how AI technologies are being applied to solve complex problems in knowledge-intensive industries.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-AI&v=1772624329261 "Schedule of future (projected) sales of companies in the market segment - AI")
Future (projected) sales of the market as a whole
Evogene Ltd. is an Israeli computational biology company using AI to improve product development in agriculture, pharmaceuticals, and manufacturing. Its success depends on the effectiveness of its platform. This graph, reflecting general trends in these industries, demonstrates the growing need for innovation that can be accelerated by Evogene's technology.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772624329295 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Evogene Ltd.
Evogene uses artificial intelligence to accelerate the development of new products in agriculture and pharmaceuticals. This chart shows the profitability of this unique scientific platform. Profits are generated through partnerships with large companies that use its technology to create new seeds, herbicides, and drugs.
Market segment marginality - AI
Evogene uses advanced computing platforms and artificial intelligence to accelerate product development in the agricultural and pharmaceutical sectors. The profitability of this technology platform depends on the success of its subsidiaries and partnerships. This chart, showing the average profitability in the sector, helps assess the potential of their business model.
Market marginality as a whole
Evogene is an Israeli company using computational biology and AI to improve product development in agriculture and pharmaceuticals. This overall market profitability curve impacts its partners. However, for Evogene, it's more important to demonstrate that its platform can accelerate and reduce the cost of research, which is valuable in any phase of the economic cycle.
Employees in the company, segment and market as a whole
Number of employees in the company Evogene Ltd.
Evogene is an Israeli company using computational biology and AI to accelerate product development in agriculture, pharmaceuticals, and manufacturing. This graph shows the team's scientists and bioinformatics specialists. Their number reflects the knowledge-intensive nature of the business.
Share of the company's employees Evogene Ltd. within the market segment - AI
Evogene Ltd. uses computational biology and AI to improve product development in agriculture and pharmaceuticals. This chart shows the percentage of bioinformaticians, geneticists, and machine learning specialists the company employs. It reflects its concentration of unique talent at the intersection of biology and IT to create innovative solutions.
Number of employees in the market segment - AI
Evogene is an Israeli company that uses computational biology and AI to develop new products in agriculture, medicine, and manufacturing. This graph illustrates how AI is becoming a universal platform for innovation, requiring specialists capable of applying machine learning algorithms to solve problems across a wide range of fields.
Number of employees in the market as a whole
Evogene Ltd. uses artificial intelligence for agricultural and biotechnology research. This is an example of how advanced IT solutions are being applied to modernize traditional industries. Accelerating R&D with AI allows for new products to be brought to market more quickly, ultimately stimulating growth and job creation, as illustrated in this graph.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Evogene Ltd. (EVGN)
Evogene is an Israeli computational biology company using AI to develop products in agriculture and medicine. This chart represents the company's net intellectual capital. The company's assets are its AI platforms (e.g., ChemPass). The chart shows how highly the market values this powerful computational technology per scientist/analyst.
%20of%20the%20company%20Evogene%20Ltd.%20(EVGN)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Evogene-Ltd.-EVGN&v=1772624329853 "Chart of market capitalization per employee (in thousands of dollars) of the company Evogene Ltd. (EVGN)")
Market capitalization per employee (in thousands of dollars) in the market segment - AI
Evogene Ltd. uses artificial intelligence to accelerate product development in agriculture and pharmaceuticals. The company's value is determined by its computing platform and team of specialists. The chart shows the market premium paid for this unique fusion of biology and AI, reflecting the potential of their technology.
%20by%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-AI&v=1772624329866 "Market capitalization per employee (in thousands of dollars) by market segment - AI")
Market capitalization per employee (in thousands of dollars) for the overall market
Evogene Ltd. is an Israeli computational biology company using AI to develop products for agriculture and medicine. This chart shows the average market capitalization per employee, highlighting the enormous value of cutting-edge scientific platforms.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772624329884 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Evogene Ltd. (EVGN)
Evogene is a biotech platform that uses AI for R&D in agriculture, pharmaceuticals, and manufacturing. This chart shows the company's per-employee cost. It reflects how much the company invests in each scientist and data scientist to run its computational R&D platform.
%20Chart%20Evogene%20Ltd.%20(EVGN)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Evogene-Ltd.-EVGN&v=1772624329899 "Company Profit Per Employee (in thousands of dollars) Chart Evogene Ltd. (EVGN)")
Profit per employee (in thousands of dollars) in the market segment - AI
Evogene Ltd. uses artificial intelligence to accelerate product development in agriculture and medicine. It's a computational biology platform. Its high profit per employee suggests that a small team of scientists and data scientists can create intellectual property with enormous commercial potential by licensing it to large companies.
%20in%20the%20market%20segment%20-%20AI&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-AI&v=1772624329913 "Chart of profit per employee (in thousands of dollars) in the market segment - AI")
Profit per employee (in thousands of dollars) for the market as a whole
Evogene (EVGN) is an Israeli AI/biotech company. They use an AI platform for R&D in three areas: agritech (pesticides, seeds), biotherapeutics (medicines), and industrial tech (chemicals). This is an R&D AI business. This chart shows the average profitability per employee across the market. It provides a benchmark for assessing how effective EVGN's AI/R&D model (IP) is in generating USD per scientist.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772624329931 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Evogene Ltd. (EVGN)
Evogene uses computational biology and AI to improve product development in agriculture and pharmaceuticals. This graph illustrates the potential of its technology platform. It reflects the company's ability to partner and generate revenue from its research, accelerating R&D for others.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Evogene-Ltd.-EVGN&v=1772624329958 "Sales chart per company employee Evogene Ltd. (EVGN)")
Sales per employee in the market segment - AI
Evogene is an Israeli biotech company using AI ("Computational Predictive Biology") to develop products in agriculture, biofuels, and medicine. This chart shows the average revenue per employee in this segment. It helps assess how effectively Evogene monetizes its AI platform compared to its competitors.
Sales per employee for the market as a whole
Evogene is an Israeli biotech company that uses an AI platform to develop products in various fields, from agriculture (seeds) to medicine (therapeutics). This chart shows the revenue (primarily affiliate fees) generated by their highly skilled R&D team monetizing their sophisticated AI platform.
Short shares by company, segment and market as a whole
Shares shorted by company Evogene Ltd. (EVGN)
Evogene is an Israeli company that uses an AI platform (Computational Predictive Biology) to develop products in agritech (seeds) and biotech (medicines). This chart shows the odds that their AI is ineffective. "Bears" believe that, despite years of work, their platform has failed to produce commercially successful products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Evogene-Ltd.-EVGN&v=1772624330076 "Short Shares Chart for the Company Evogene Ltd. (EVGN)")
Shares shorted by market segment - AI
Evogene Ltd. is an Israeli company using computational biology and AI to improve product development in agriculture (seeds), biofuels, and medicine. This chart shows the overall bearish bets across the entire AI biotech sector. If the bearish bets are rising, it means investors generally doubt AI can quickly and cost-effectively create new products in these industries.
Shares shorted by the overall market
Evogene is an Israeli company using an AI platform to develop new drugs and agricultural technologies. It's a complex, science-intensive business. This chart measures overall fear. When investors are fearful, they avoid complex stories, micro-caps, and geopolitical risks (Israel). EVGN combines all of these factors, making it an easy sell-off target.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Evogene Ltd. (EVGN)
Evogene Ltd. is an Israeli company using computational biology (AI) to develop products in agriculture (agritech) and medicine (biotech). This indicator tracks the hype surrounding AI in biology, indicating "overheating" (above 70) on news of breakthroughs at its subsidiaries or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Evogene-Ltd.-EVGN&v=1772624330114 "RSI 14 indicator chart for the company's stock Evogene Ltd. (EVGN)")
RSI 14 Market Segment - AI
Evogene is an Israeli computational biology (AI) company. Their platform is used to develop new products in agriculture (pesticides, seeds) and medicine. This chart reflects the collective excitement in the AI and biotech sectors. It helps determine whether the entire segment is overheated by expectations of a breakthrough in AI medicine.
RSI 14 for the overall market
Evogene, an "AI" biotech, sees this chart as hype and capital availability. In the euphoria, investors are ready to finance the "future" (AI + biotech). In a panic, they flee unprofitable R&D projects, and the cash flow to Evogene, which is burning through hundreds of millions, could be shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast EVGN (Evogene Ltd.)
Evogene uses its computational biology (AI) platform for R&D in various sectors: agriculture (AgPlenus), medicine (Biomica), and industry (Castera). This chart shows the average analyst forecast. Their targets are based on the progress of their subsidiary companies and the formation of new partnerships that confirm the value of their AI platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-EVGN-Evogene-Ltd.&v=1772624330271 "A chart showing analyst consensus forecasts for the expected stock price. EVGN (Evogene Ltd.)")
The difference between the consensus estimate and the actual stock price EVGN (Evogene Ltd.)
Evogene is an Israeli biotech parent company. It uses its AI platform (CPB) to create subsidiaries in various fields, from agrochemicals to medicine. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and the forecast, reflecting their "aggregate" valuation of this AI platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-EVGN-Evogene-Ltd.&v=1772624330316 "A chart showing the difference between the consensus forecast and the actual stock price. EVGN (Evogene Ltd.)")
Analyst consensus forecast for stock prices by market segment - AI
Evogene is an Israeli "AI biologist." The company uses its computing platform to develop new products in agritech (seeds) and medicine (medicines). This chart shows analysts' overall expectations for the entire AI sector. It reflects whether experts believe AI can accelerate R&D in the "real" sector.
Analysts' consensus forecast for the overall market share price
Evogene (EVGN) is an Israeli "AI factory" for biotech. They use their computing platform to "create" new products in agriculture (seeds), medicine (microbiome), and manufacturing. This chart shows the overall risk appetite, reflecting the willingness of investors to invest in hyped but unprofitable AI-based R&D platforms.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Evogene Ltd.
Evogene is an Israeli-based AI biotech company. They don't have a single R&D team; they have a platform (MicroBoost AI, ChemPass AI) that uses AI to predict and develop new products in agrochemicals (seeds, pesticides) and medicine (cannabis). This chart is a summary indicator of their AI platform. It reflects their (slow) progress in R&D and their ability to form partnerships.
AKIMA Market Segment Index - AI
Evogene (EVGN) is an Israeli computational biotech company. They use an AI platform (MicroBoost AI) to discover and develop new products in agriculture, medicine, and manufacturing. This chart shows the average index for the segment, helping investors assess how this AI-powered R&D company compares to the average.
The AKIM Index for the overall market
Evogene is an Israeli computational biology company using AI to discover new products in agriculture, pharma, and other industrial sectors. This chart, which reflects the market average, provides context. It helps assess how this innovation powerhouse and its subsidiaries stack up against broader macroeconomic trends.
